Ian Haydock
Verified
Tokyo-based Editor-in-Chief, Asia-Pacific, for @PharmaScrip @PharmaPinkSheet, @citeline, @NorstellaCo. All views my own, RTs not endorsements.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ian
Contact Ian, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Ian Haydock’s Biography
Read Full Bio →Ian is based in Tokyo and covers the Asian pharma markets for Scrip and its sister publication PharmAsia News (www.pharmasianews.com), of which he is managing editor. He writes about a broad range of business strategy and development, policy/regulatory and R&D issues relevant to both big pharma and smaller start-up firms, and has a particular interest in regulatory convergence initiatives in Asia. Ian has also covered of the Australian bioventure sector and aims to provide an analytical angle o…